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Functional genomic analysis and related strategies for genetic control of malaria rely on validated and reproducible
methods to accurately modify the genome of Anopheles mosquitoes. Amongst these methods, the φC31 system
allows precise and stable site-directed integration of transgenes, or the substitution of integrated transgenic cassettes
via recombinase-mediated cassette exchange (RMCE). This method relies on the action of the Streptomyces φC31
bacteriophage integrase to catalyze recombination between two specific attachment sites designated attP (derived from
the phage) and attB (derived from the host bacterium). The system uses one or two attP sites that have been integrated
previously into the mosquito genome and attB site(s) in the donor template DNA. Here we illustrate how to stably modify
the genome of attP-bearing Anopheles docking lines using two plasmids: an attB-tagged donor carrying the integration
or exchange template and a helper plasmid encoding the φC31 integrase. We report two representative results of φC31-
mediated site-directed modification: the single integration of a transgenic cassette in An. stephensi and RMCE in An.
gambiae mosquitoes. φC31-mediated genome manipulation offers the advantage of reproducible transgene expression
from validated, fitness neutral genomic sites, allowing comparative qualitative and quantitative analyses of phenotypes.
The site-directed nature of the integration also substantially simplifies the validation of the single insertion site and the
mating scheme to obtain a stable transgenic line. These and other characteristics make the φC31 system an essential
component of the genetic toolkit for the transgenic manipulation of malaria mosquitoes and other insect vectors.
Introduction
The ability to modify the genome of mosquito vectors of
diseases reliably and reproducibly has bolstered in vivo
functional validation of genes and opened the doors to
realizable genetic vector control strategies, such as those
targeting Anopheles mosquitoes that transmit malaria1 .
Copyright © 2021  JoVE Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported
License
jove.com February 2021 • 168 •  e62146 • Page 2 of 22
Early mosquito genome editing relied solely on transposable
element (TE)-mediated transformation, with piggyBac being
the most commonly used transposon in Anopheles2,3 ,4 .
However, the random nature of TE integration can lead
to undesirable modifications such as gene knockouts
(insertional mutagenesis) and significant position effects on
transgene expression5,6 ,7 ,8 . Multiple insertions are also a
common occurrence when using piggyBac5,9 , which makes
the validation and the isolation of transgenic lines with
single insertions laborious. Other drawbacks include their
potential remobilization, as observed in the germline of
Anopheles stephensi when providing a source of piggyBac
transposase10,11 ,12 , and their limited size of DNA cargo
(10-15 kb in length) with transformation efficiency declining
with increasing size of the donor plasmid13,14 .
Site-directed integration approaches were introduced to
circumvent these issues. The most common site-directed
genome modification in mosquitoes is that mediated by the
φC31 system (Figure 1a). This is driven by a viral integrase
that catalyzes the recombination between two heterospecific
attachment (att) sites occurring naturally in the genome of
the bacteriophage φC31 (attP) and in the Streptomyces
bacterium host (attB)15 . Recombination of the two sites is
unidirectional and results in the formation of hybrid sites (attL
and attR). The recombination of such hybrid sites (leading
to DNA excision) would require not only the presence of
an active viral integrase but also another phage-encoded
recombination factor16,17 . A stable integration site is thus
generated that relieves the issue of potential undesired
remobilization15 . Moreover, the system allows the integration
of large cargoes (e.g., integration of >100 kb constructs
was reported in D. melanogaster18 ), significantly increasing
carrying capacities. Integration occurs in a single predefined
genomic locus which greatly simplifies the validation of
insertion and the mating scheme to obtain a stable transgenic
line. Finally, the site-directed nature of the integration allows
normalization of expression as alternative transgenes are
located in the same locus and therefore are regulated within
the same neighboring genomic context. Indeed, one of the
main applications of the technique is the direct comparison
of phenotypes conferred by different transgenes following
insertion into an identical locus.
Achieving φC31-mediated integration involves two phases:
phase I is the creation of transgenic docking lines carrying
attP site(s), and phase II is the site-directed integration of
an attB-flanked cargo in the genome of the docking line19 .
The creation of phase I docking lines has relied on the
TE-mediated random integration of attP-tagged constructs
and thus involved an initial laborious process (including
southern blot and inverse PCR analyses on single-female
progeny) to isolate and validate transgenic lines carrying a
single integration event in unique, transcriptionally active,
and fitness neutral genomic locations. Nevertheless, several
docking lines for φC31-mediated single integration have
been developed and validated in An. gambiae19,20 ,21 ,22
and in An. stephensi23,24 ,25  (Table 1). Each of these lines
varies in terms of the genomic location of the docking site
and the strain-specific genetic background and from them a
great variety of new transgenic lines can be created. The
complex validation of TE-mediated integrations for producing
docking lines can now be circumvented by the CRISPR/Cas9
technology26 ; however this relies on the a priori knowledge of
neutral loci to be targeted and their surrounding sequences.
φC31-mediated integration has been applied extensively
to insect genome editing from the model organism D.
melanogaster27 , to the mosquitoes Aedes aegypti13,28 , Ae.
albopictus29 , An. gambiae19 , and An. stephensi24 , as well
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as other insects including Ceratitis capitata30  and Bombyx
mori31 .
A limitation of φC31-mediated integration, especially in
view of potential field releases for vector control, is the
integration in the mosquito genome of the entire attB-
bearing donor plasmid, including undesirable sequences
such as antibiotic-resistance gene markers and plasmid
backbone components of bacterial origin. To address this, a
modification of the standard system, recombinase-mediated
cassette exchange (RMCE), was implemented that allows
the precise replacement of a previously integrated transgenic
cassette with a new donor DNA (Figure 1b). This is achieved
by using two inverted att sites flanking the donor and
recipient cassettes at each end, which drives two independent
recombination events to take place simultaneously resulting
in cassette exchange without integration of the plasmid
backbone. This improved design circumvents the integration
of undesired sequences and expands the application of φC31
systems to include for example the integration of unmarked
DNA cargos by screening for the loss of a previously
integrated fluorescent marker32 .
RMCE was achieved first with D. melanogaster32  and later
applied successfully to non-model insects including An.
gambiae9,26 ,33 , Ae. aegypti34 , Plutella xylostella34 , and
B. mori35 . Several docking lines for RMCE have been
developed and validated in An. gambiae5,9 ,26  (Table 1).
To our knowledge, RMCE is yet to be explored in other
Anopheles vectors species.
To date, the φC31 system has been used widely in Anopheles
mosquitoes to introduce and study a variety of molecules
including antimalaria effectors19,24 ,36 , components of the
GAL4/UAS system to overexpress and knockdown genes
for insecticide resistance studies9,33 , regulatory elements,
reporter genes5,21 ,37 , and gene-drive elements26,38 .
This protocol describes how to perform 1) site-directed
integration of an attB-flanked cargo and 2) RMCE of a
construct flanked by inverted attB sites into the genome
of Anopheles docking lines. This is achieved by using two
plasmids: a donor attB-tagged plasmid carrying the transgene
of interest, and a helper plasmid expressing the φC31
integrase. The major malaria vectors An. gambiae and An.
stephensi are used as specific examples, however these
protocols are applicable to other Anopheles species.
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Figure 1. Site-directed genome modifications, single integration and recombinase-mediated cassette exchange
(RMCE) , using the φC31 system. The φC31 integrase (INT, grey double arrow) catalyzes the recombination between
the attB site(s) (purple striped) present in a donor plasmid and the attP site(s) (blue striped) present in a receiving docking
line, which results in the formation of hybrid sites attL and attR. A) Integration is achieved when single attB and attP sites
recombine and results in the presence of two integrated markers (blue and red). B) RMCE occurs when two attB/P sites
recombine simultaneously and results in the replacement of the cassette between the att sites of the docking line (blue
marker) with that carried by the donor plasmid (red marker). C) Partial nucleotide sequences of attP (blue) and attB (purple)
and the hybrid sites attL/R. Recombination occurs between the 'TT' core sequences highlighted in bold black. Please click
here to view a larger version of this figure.
Protocol
NOTE: A schematic workflow of the illustrated protocol is
shown in Figure 2.
1. Design of φC31 attB -tagged plasmids (Figure
3)
1. Create attB donor plasmids carrying the following
essential components
1. Dominant fluorescent marker
1. Choose a promoter to drive the expression of
the fluorescent marker.
 
NOTE: For Anopheles transgenesis,
fluorescent markers are usually under the
regulation of the 3xP3 promoter39 , which
drives expression in the eyes and nerve cord.
Alternatively, the PUBc promoter5  can be used
when expression in multiple tissues is desired.
Donor plasmids and docking lines used as
examples in this protocol are marked using the
3xP3 promoter.
2. Choose a fluorescent protein (FP) that is
compatible with that of the receiving docking
line so that they are readily distinguishable.
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NOTE: Do not use the same marker that is
already present in the docking line and avoid the
simultaneous use of GFP (green)/YFP (yellow)
and GFP (green)/CFP (cyan) as they are very
difficult to reliably differentiate. Donor plasmids
used as examples in this protocol are marked
with either DsRed or YFP as they are to be
integrated in a docking line marked with CFP.
2. attB recombination site(s)
1. Use a single attB site for integration of
a transgenic cassette (single-attB design)
(Figure 3A).
2. Use two inverted attB sites for RMCE
(double-attB design) where the sites lay
inverted in respect to one another and enclose
the donor DNA template (Figure 3B).
 
NOTE: The orientation of the attB site(s) must
be compatible with that of the attP site(s)
present in the docking line.
3. Desired transgene cargo
1. Use any other desired features to be integrated
in the mosquito genome based on the specific
purpose of the experiment. Here, we describe
the integration of an antimalarial effector
molecule into the genome of An. stephensi and
the integration of the components of the GAL4/
UAS system into An. gambiae mosquitoes.
4. Plasmid backbone components
1. Include, amongst other essential components
for plasmid replication in bacteria, a marker
for plasmid selection in vitro (i.e., an antibiotic
resistance gene).
 
NOTE: The plasmid backbone will be integrated
in the mosquito genome in the single-attB
design for integration (Figure 3A), while it will
not be inserted in the double-attB design for
RMCE (Figure 3B).
2. Preparation of plasmids for the microinjection
mix
NOTE: The protocol illustrated here involves the use of
two plasmids: an attB-tagged donor plasmid carrying the
transgene of interest, and a helper plasmid that expresses the
φC31 integrase under the regulation of the Drosophila Hsp70
promoter40 .
1. Purify donor and helper plasmids using an endotoxin-free
plasmid purification kit.
 
NOTE: Sequence the final plasmid preparation used for
injection to verify the integrity of all components.
2. Combine appropriate amounts of the two plasmids to
obtain a mix with a final concentration of 350 ng/µL of the
donor plasmid and 150 ng/µL of the helper plasmid when
resuspended in injection buffer.
 
NOTE: When calculating the necessary volume of
mix, consider that 10-15 µL are sufficient for each
day of planned injections and DNA can be prepared
in advance and stored at -20 °C. Integrase helper
plasmid concentrations of 60-500 ng/µL and donor
plasmid concentrations of 85-200 ng/µL have also been
reported21,22 ,26 ,41 .
3. Precipitate the DNA by adding 0.1 volumes of 3 M
sodium acetate (pH 5.2) and 2.5 volumes of ice-cold
100% EtOH and vortex. A white precipitate should
be immediately visible. Having highly concentrated
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initial plasmid preparations (i.e., ~1 µg/µL) improves
precipitation efficiency.
 
NOTE: Stopping point - The precipitate can be stored at
-20 °C overnight.
4. Centrifuge at 15,000 x g for 20 min at 4 °C, discard the
supernatant, and wash the pellet with 1 mL of ice-cold
70% EtOH.
5. Wash the pellet with 1 mL of ice-cold 70% EtOH and
centrifuge at 15,000 x g for 5 min at room temperature.
6. Discard the supernatant without disturbing the pellet and
air dry.
7. Resuspend the pellet in 1x injection buffer (0.1 mM
Na3PO4, 5 mM KCl, pH 7.2, 0.22 µm filter sterilized) to
reach a total final concentration of 500 ng/µL.
 
NOTE: Assume that some DNA will be lost during the
precipitation process; therefore, add a smaller volume
of injection buffer first, check the concentration on a
spectrophotometer (e.g., Nanodrop), and then add an
appropriate remaining volume to reach 500 ng/µL.
8. Ensure that the DNA is thoroughly resuspended, prepare
aliquots of 10-15 µL each and store them at -20 °C.
9. On the day of injection, thaw one aliquot and centrifuge at
15,000 x g for 5 min to remove any particulate residues.
 
NOTE: An alternative method for particulate removal
is to filter the solution through a 0.22 µm filter. Avoid
the presence of particulate residues in the injection
mix as they lead to needle blockage during embryo
microinjection.
3. Microinjection of embryos from an Anopheles
docking line
1. Blood feed 4-7-day-old mosquitoes from the desired
docking line 72 h prior to microinjection (i.e., for injection
on Monday and Tuesday feed females on the previous
Friday; for injection on Thursday and Friday feed females
on Monday of the same week).
2. Blood feed wild-type (WT) mosquitoes (i.e., mosquitoes
with the same genomic background of the docking line)
on the same day; these will be needed for outcrossing.
 
NOTE: The size and quality of the blood meal affect
egg quality, so it is recommended to always use fresh
blood (i.e., blood drawn within the previous 7 days).
Arm feeding or feeding on mice may increase the
quality and quantity of eggs, however these methods
are not encouraged. Specific approved protocols will be
necessary for human and animal use.
3. Perform embryo microinjections
1. Perform An. gambiae embryo microinjections in 25
mM NaCl42  by targeting the posterior pole of the
embryo at a 45-degree angle. For a detailed protocol
for embryo collection, alignment, and microinjection
refer to Pondeville et al.43  and Lobo et al.44 .
2. Perform An. stephensi embryo microinjections in
halocarbon oil 700:27 (2:1) by targeting the posterior
pole of the embryo at a 30-degree angle. A
detailed protocol for embryo collection, alignment,
and microinjection can be found in Terenius et al.45
and Lobo et al.44 .
3. Transfer eggs immediately after injection in a Petri
dish filled with sterile distilled water (pH 7.2) and
return them to insectary conditions.
4. Upon hatching, transfer G0 larvae into a tray with salted
distilled water (0.1% tonic salt) daily and rear to pupae.
5. Record hatching rate (i.e., number of larvae hatched/
number of embryos injected).
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NOTE: Embryo movement aids hatching, so gentle
swirling is desirable. Hatching should start ~48 h
after injection. Since injection may cause a slight
developmental delay it is advisable to keep monitoring
for late-hatching larvae for 3-4 days.
4. Crossing and screening of transformed
individuals
1. [OPTIONAL STEP] Screen G0 (injected) 1st  or 2nd  instar
larvae (L1-L2) for transient expression of the fluorescent
marker.
1. Use a fine-tip glass pipette to transfer G0 L1-L2
larvae to a microscope slides with wells. Place one
larva in each well.
2. Use a fluorescence stereoscope with the
appropriate filter to screen for the presence of
transient expression of the fluorescent marker.
 
NOTE: The pattern of transient expression is
dictated by the promoter used. When using the 3xP3
promoter, transient expression of the fluorescent
marker is visible in the anal papillae (see Figure 6
in Pondeville et al.43 )
3. Rear G0 positive individuals separately.
2. Sort G0 pupae by sex under a stereoscope52 .
3. Let males emerge in separate cages in groups of 3-5
(founder families) and add a 10-fold excess of age-
matched WT females.
 
NOTE: Since males mate multiple times, it is important to
provide an excess of WT females to maximize the mating
chances of each male.
4. Let females emerge in separate cages in groups of 10-15
(founder families) and add an equal number of age-
matched WT males.
 
NOTE: If there is limited space in the insectary, females
can emerge all together in a single cage. The female to
male ratio can be as low as 1 male to 3 females.
5. Allow adults to mate for 4-5 days and provide females
with a blood meal.
 
NOTE: Blood feed and collect eggs from G0 females
multiple times to maximize the chances of getting
transformants from multiple gonotrophic cycles.
6. Blood feed WT individuals at the same time for
outcrossing.
7. Collect eggs and rear emerging next generation G1s.
8. Screen G1 L3-L4 larvae for appropriate fluorescence to
identify transformants.
1. Collect larvae in a Petri dish lined with filter paper
or on a microscope slide and screen using a
fluorescent stereoscope with appropriate filters for
the presence of the marker introduced with the attB-
tagged cargo.
 
NOTE: Fluorescence driven by the 3xP3 promoter
is visible in all postembryonic stages and the
screening may be performed on younger larvae,
however these are more fragile and must be handled
relatively carefully. Pupae can also be screened.
1. For single-attB designs for integration screen
for the presence of the new and pre-existing
marker; they should both be present since the
new cassette is inserted next to the original one
(Figure 3A, Figure 4).
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NOTE: Screening exception for single attB
designs: When using marker-less docking
lines22 , screen for the presence of the new
marker only. When using docking lines where
integration results in the inactivation of the pre-
existing marker21 , screen for the presence of
the new marker and the loss of the pre-existing
one.
2. For double-attB designs for RMCE, screen
for the presence of the new marker and the
loss of the pre-existing one, only the newly
introduced marker should be present since the
new cassette replaces the original one (Figure
3B, Figure 5).
 
NOTE: Occasional integration events can be
recovered in RMCE experiments where only a
single attP recombined and thus both markers
will be present. The screening of G1 individuals
can be carried out also at the pupa stage
following the same procedure52 .
9. Transfer transformed G1 individuals into a larval tray
and rear to pupae. Discard non-fluorescent individuals
and individuals with an unexpected marker expression
pattern.
10. Sort transformed G1 pupae by sex and cross them en
masse with opposite-sex age-matched WT individuals.
11. Allow adults to mate for 4-5 days, provide a blood
meal, collect the eggs, and rear the next generation G2
progeny.
1. For single integration experiments, collect eggs
directly from the en masse cross as the integration
site is identical in all individuals.
2. For RMCE experiments, collect eggs from single
females and maintain progeny separate until
molecular assessment is complete due to the
potential presence of two alternative cassette
orientations (Figure 3B).
12. Screen the G2 progeny (at either the larva or pupa stage)
for the presence of the fluorescent marker (50% of the
individuals are expected to be positive), discard non-
fluorescent progeny.
13. Set aside a subset of G2 positive individuals for
molecular analysis, rear the rest to adulthood.
 
NOTE: If all G2 individuals must be kept alive, molecular
analysis can be conducted on single adult's legs46
or pupal case DNA extractions (L. Grigoraki personal
communication). Alternatively, molecular analysis can be
performed after all the G2 individuals have oviposited
and eggs have hatched.
14. Allow adult males and females to intercross in the same
cage to establish the new transgenic line.
 
NOTE: For RMCE experiments, adult intercross must
occur between siblings deriving from a single female
until orientation of insertion is determined via molecular
analysis.
5. Molecular validation of the insertion site by
DNA amplification (PCR)
1. Prepare a map of the predicted insertion site in the
genome of the docking line after transformation.
1. Single integration: Ensure that the predicted
insertion site carries the original docking construct
plus the whole sequence of the donor plasmid
between the two hybrid sites attL and attR (Figure
3A).
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2. RMCE: Ensure that the predicted insertion site is
identical to that of the docking line where hybrid
inverted attL sites replace the original inverted
attP sites and the exchange template replaces the
cassette originally present between them (Figure
3B).
2. Design oligonucleotide primers to amplify the insertional
junction at either side of the integration locus.
1. Single integration: Design oligonucleotide primer
pairs that span across the attR and/or attL sites.
One primer must bind to the previously integrated
docking construct and the other to the newly
integrated transgene (Figure 3A).
2. RMCE: Cassette replacement can occur in
two different orientations with respect to the
chromosome (designated A and B). Design
alternative combinations of 4 oligonucleotide
primers to give a discrete product in only one of
the orientations, with one pair being diagnostic for
orientation A, and the other for orientation B (Figure
3B, Figure 6).
3. Extract genomic DNA from G2 positive individuals and
perform the diagnostic PCR and gel electrophoresis to
visualize the presence of expected diagnostic amplicons
from the predicted integration site maps.
 
NOTE: DNA may alternatively be extracted from single
adult's legs46  or pupal cases (L. Grigoraki personal
communication).
4. Sequence PCR products to confirm expected
sequences.
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Figure 2. Workflow diagram for site-directed φC31 genome modification in Anopheles mosquitoes. Please click here
to view a larger version of this figure.
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Figure 3. Molecular basis of φC31-mediated single integration (A) and RMCE (B).  A) Schematic maps of the genomic
insertion in an An. stephensi docking line (80.9, Table 1) carrying a single attP site and marked with CFP (top), a single-attB
design donor plasmid marked with DsRed (middle), and the expected insertion site resulting after successful integration
(bottom). B) Schematic maps of the genomic insertion in an An. gambiae docking line (A11, Table 1) carrying two inverted
attP sites and marked with CFP (top), a double-attB design donor plasmid marked with YFP (middle), and the expected
insertion site resulting after successful RMCE (bottom). Wavy line: mosquito genome; Striped arrows: piggyBac transposon
arms; 3xP3: promoter of the fluorescent marker; SV40: viral terminator; Ori: origin of replication; AmpR: ampicillin resistance
gene. Crossing lines represent the site(s) of recombination between attP and attB sites. Numbered black arrows represent
primer binding sites for the molecular validation of the insertion locus (step 5 of the protocol). Fully annotated single and
double attB-tagged plasmids are available from the authors upon request. Please click here to view a larger version of this
figure.
Representative Results
The protocol illustrated here enables to generate a stable
Anopheles transgenic line in ~10 weeks (assuming a 21-day
mosquito life cycle).
Post-injection larval hatching rates in An. gambiae are
expected to be generally lower than An. stephensi,
however hatching rates between 10-50% have been
reported9,20 ,24 ,26 ,33 ,43 ,47 . Given appropriate injection
technique, hatching rates of ≥20% are generally sufficient
to yield transformants. DNA uptake by the embryos can be
assessed by screening young larvae for transient expression
of the fluorescent marker. In successful RMCE experiments
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in An. gambiae using the 3xP3 promoter up to 50% of
the surviving G0 larvae showed episomal expression of the
marker in the anal papillae48 .
Generalized estimates of transformation efficiency are difficult
to evaluate among laboratories and even among experiments
as transformation depends on a complex interplay of
variables including purity, concentration, size, and potential
toxicity of the injected DNA, quality of eggs, pre- and
post-injection handling of eggs, mosquito rearing, and most
importantly the experience of the operator. Transformation
rates up to 7% have been obtained for RMCE in An. gambiae
(calculated as the number of independent transformation
events in the total G0 individuals)9,26 ,33 , and up to 2.2%
transformation rate for integration in An. stephensi. We
suggest injecting at least 500 embryos, which should lead
to the hatching of at least 100 G0 larvae and to 2-7 G0
adult founders from which stably transformed progeny can be
obtained. If screening for transient expression in G0 larvae,
up to 40 positive larvae can be expected.
Examples of phenotypic validation of transformation via the
screening of fluorescent markers regulated by the 3xP3
promoter are reported in Figure 4 and Figure 5. Figure
4 shows a new An. stephensi line obtained by insertion of
a DsRed-marked cassette into a docking line marked with
CFP (80.9, Table 1), resulting in G1 progeny expressing
both markers as indicated by the red and blue fluorescence
detected in the eyes.
RMCE designs are instead expected to result in the
replacement of the marker originally inserted into the docking
line with that of the donor plasmid. Figure 5A and Figure B
illustrate this marker exchange in an An. gambiae docking
line marked with CFP (A11, Table 1) where after successful
RMCE the CFP marker is lost and the YFP marker is
acquired resulting in yellow (but not blue) eye and nerve
cord fluorescence33 . Occasionally, RMCE can result in a
single integration event instead of the exchange of the desired
transgenic cassette as illustrated in Figure 5C, where a larva
marked with both the original CFP and the new YFP markers
is shown. It is reported that up to 50% of the total number of
transformation events are single integrations9,  33 .
When screening for the presence of a fluorescent marker
it is crucial to distinguish its signal from possible
background autofluorescence. This is particularly important
when using CFP as Anopheles larvae display natural blue
autofluorescence (Figure 6A). Increasing the magnification
and focusing on the tissues and organs where fluorescence is
expected to be driven by the promoter is necessary to identify
true CFP-positive individuals as illustrated in Figure 6B using
the 3xP3-CFP marker.
Individual transformants are finally assessed molecularly
via PCR to confirm the expected insertion site. Figure 7
reports the PCR validation in individuals from an exchange
An. gambiae line showing the two potential orientations of
insertion in the mosquito genome33 .
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Figure 4. Validation of φC31 single integration in An. stephensi larvae (dorsal view). A) The docking line (80.9, Table
1) expresses CFP in the eyes under the regulation of the 3xP3 promoter. B) Successful integration results in the expression
of the newly acquired DsRed as well as the original CFP marker in the eyes. Please click here to view a larger version of this
figure.
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Figure 5. Validation of φC31 RMCE in An. gambiae larvae (ventral view). A) The docking line (A10, Table 1) expresses
CFP under the regulation of the 3xP3 promoter in the eyes (e) and the nerve cord (nc)5 . B) Successful RMCE results in the
swap of fluorescent marker from CFP to YFP33 . C) Single integration event occurred during RMCE experiment where the
transformant larva expresses both the CFP and YFP markers. This larva carries GAL4/UAS components that cause a broad
expression pattern of YFP, particularly strong in the abdominal muscles (am). Please click here to view a larger version of
this figure.
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Figure 6. CFP autofluorescence in An. gambiae larvae (dorsal view). A) Side-by-side image of a positive (CFP+) and a
negative (CFP-) L4 larva using the CFP filter. B) Close-up image of the larval eyes that reveals a CFP+ vs CFP- individual.
Please click here to view a larger version of this figure.
 
Figure 7. Molecular validation of the orientation of cassette insertion in representative transgenic An. gambiae
created by φC31 RMCE. The transgenic cassette can be inserted in one of two alternative orientations (A or B) in respect
to the insertion site. Each PCR reaction (I - IV) uses a combination of primers (5-8)33  designed to give a diagnostic
amplification fragment for each orientation as indicated in the schematic plasmid maps. T1: representative transgenic
individual carrying orientation of insertion A; T2: representative transgenic individual carrying orientation of insertion B; WT:
wild type; DL: docking line; -: reaction negative control where water was used as template.This figure has been modified from
Adolfi et al. (2019)33 . Please click here to view a larger version of this figure.
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An. gambiae KIL Ec Single 3R 3xP3-eCFP Keele Univ. 19, 43
An. gambiae G3 X1 Single 2L No marker Univ. of
Strasbourg
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a. Strain from Johns Hopkins University (gift of M. Jacobs-
Lorena) and in culture at the Univ. of California Irvine for >20 years.
b. These lines are available from the authors upon reasonable request.
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c. This line is available at the BEI repository www.beiresources.org as MRA-1163.
Table 1. Anopheles attP docking lines.
Discussion
The accurate design of attB-tagged plasmids that are
compatible with the docking line of choice is paramount
for the success of the experiment. Careful consideration
must be given to the choice of the marker used for the
screening of transformants, including the fluorescence color
and its pattern of expression, which will be subject to the
pattern already present in the docking line. It is necessary
to use fluorescent markers that are easily distinguishable:
good marker combinations include RFP (red)/CFP (cyan),
RFP (red)/GFP (green), RFP (red)/YFP (yellow), and YFP
(yellow)/CFP (cyan), while combinations to avoid are YFP
(yellow)/GFP (green) and CFP (cyan)/GFP (green). The
3xP3 promoter39 , specific to the eyes and nerve cord,
is the most frequently used to drive the expression of
fluorescent markers for mosquito transgenesis. Indeed, all
the Anopheles docking lines currently available utilize this
promoter. Alternative regulatory regions are that of the An.
gambiae polyubiquitin gene (PUBc)5  or the viral promoter
IE120 , which drive expression in multiple tissues. When
used along with 3xP3, these promoters would expand the
possible color combinations and even the use of the same
fluorophore. The indicated promoters are active throughout
the mosquito life cycle allowing screening and fluorescence
monitoring at all life stages. An additional consideration during
plasmid design is the size of the cargo to be integrated or
exchanged. While the φC31 system has remarkable carrying
capacities18 , it should be considered that the size of the donor
plasmid generally correlates negatively with transformation
efficiency22 .
In the described protocol the source of integrase is a
helper plasmid expressing the enzyme ubiquitously40 . The
ubiquitous presence of the integrase may lead to the
transformation of somatic cells if microinjections are not
precisely directed to the area where the germline forms.
While such transformation events will be lost as they are
not heritable, somatic effects can decrease the fitness of
injected individuals. To avoid this and increase transformation
efficiency, integrase expression can be restricted to the
germline, for example by using the vasa promoter22,26 . Other
protocols describe the use of in vitro transcribed messenger
RNA (mRNA) as source of φC31 integrase19,24 ,43 .
However, this involves the laborious preparation of mRNA
and requires careful handling of the injection mix and
the use of RNase free reagents to avoid degradation.
Plasmid sources of integrase have been demonstrated in
both An. gambiae9,21 ,22 ,26 ,33 ,37  and An. stephensi (A.A.
personal communication) to be reliable and lead to efficient
transformation, and are thus our preferred option. A further
option for integrase delivery is its in vivo production in self-
docking helper lines. Such lines were created in An. gambiae
that express the φC31 integrase under the regulation of
the germline-specific promoter nanos and were found to
lead to an improved survival and transformation efficiency20 .
However, potential fitness loads imposed by the in vivo
production of the integrase enzyme on the helper line must
be considered.
As with other transgenic techniques, special care must
be reserved to the rearing and crossing of individuals
deriving from injected embryos to maximize the chances
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to recover transformants. Individuals that have stably
inherited the transgene can be firstly recovered at the G1
progeny. However, early signs of potential transformation
can be evaluated by the presence of transient episomal
expression of the fluorescent marker in the anal papillae
and/or nerve cord of G0 first and second instar larvae
when using the 3xP3 promoter43 . While the presence of
transient fluorescence suggests successful plasmid delivery,
it does not guarantee heritable germline transformation.
Similarly, the lack of transient expression does not
exclude successful transformation. Nevertheless, it has been
observed that transiently positive individuals are more likely
to yield transgenic progeny compared to transiently negative
ones43,48 . In expert hands, rearing and crossing of only
positive individuals may be an option to reduce mosquito
numbers. However, given the importance and fragility of small
G0 larvae, the least amount of manipulation is still advisable
and the rearing of all G0 individuals is always recommended.
The mating scheme reported in this protocol is designed to
maximize the chance of mating and to isolate independent
transformation events. However, if insectary space or
personnel availability is an issue, G0 adults can be pooled
by sex in single cages if enough opposite-sex individuals are
provided. Such a setup will not allow discrimination between
multiple transformation events occurring in individuals from
the same cage. Depending on the experimental setup,
the presence of a double (single integration) or single
(RMCE) marker is expected during the screening process.
In single integration experiments it is important to verify the
presence of the original marker from the docking line, while
in RMCE is important to verify the loss of the previously
integrated marker. Indeed, it is not uncommon in RMCE
designs to recover transformants in which single integration
instead of exchange occurred due to the recombination of
a single attP site9,33 . In such individuals both fluorescent
markers are present as well as the whole donor plasmid
backbone highlighting the importance of conducting a
thorough screening for both fluorescent markers.
While the presence of expected fluorescence
patterns indicates successful transformation, molecular
characterization of the insertion site must be undertaken. To
do so, the preparation of accurate maps of the predicted
insertion locus, including the flanking genomic regions of
the docking line, is crucial for the design of adequate
diagnostic oligonucleotide primers for gene amplification
analyses. Single integration events result in the formation of
attR and attL hybrid sites at the junction between the newly
integrated DNA and the previously inserted cassette. These
sites can be targeted for insertion site validation. In RMCE
designs, the insertion of the donor cassette can occur in two
alternative orientations in respect to the genomic locus, thus
four primers can be used in alternative PCR combinations to
detect which orientation the line carries. As the orientation
of cassette insertion may affect transgene expression, in
comparative gene expression analysis it is important to use
lines carrying the same orientation of insertion.
When working with low numbers of transformants it may
not be desirable to sacrifice whole individuals for molecular
analysis. An option to this is conducting molecular analysis on
DNA extracted from single adult's legs46  as leg loss does not
affect an adult female ability to mate and oviposit49 . However,
there is a risk of damaging the individual in the process of
leg removal. Success has been obtained using discarded
pupal cases (L. Grigoraki personal communication), however
the safest approach is to perform molecular analysis on G2
parents after obtaining viable G3 progeny.
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In recent years, CRISPR/Cas9 has revolutionized the
way of performing site-specific genome editing26,41 ,50 ,51 .
Unlike site-directed RMCE, CRISPR/Cas9-mediated gene
integrations (knock-ins) are independent of the presence
of pre-inserted recombination sites with only a one-step
transformation event needed. Nevertheless, the CRISPR/
Cas9 system relies on the presence of large known genomic
sequences flanking the desired insertion site for successful
homology directed repair as well as on the efficient site
recognition mediated by guide RNAs. These conditions
cannot always be met or may be laborious to troubleshoot
and, given the availability of multiple docking lines in An.
gambiae and An. stephensi and lines derived from them, the
φC31 system remains a very valuable tool to perform direct
phenotypic comparisons between transgenes at the same
genomic locations.
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